Immunodomination during peripheral vaccinia virus infection

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Immunodominance, a key feature of CD8(+) T cell responses, is known to be influenced by the route of administration.
• Previous studies examined limited epitopes and lacked mechanistic explanations for altered immunodominance post-vaccinia virus (VACV) infection.

Purpose of the Study:

• To investigate how different administration routes affect CD8(+) T cell immunodominance against VACV.
• To elucidate the underlying mechanisms driving route-dependent immunodominance.

Main Methods:

• Examined 15 VACV epitopes across four administration routes: intradermal (i.d.), subcutaneous (s.c.), intraperitoneal (i.p.), and intravenous (i.v.).
• Tracked virus dissemination, analyzed T cell priming sites, and utilized experiments to restrict viral spread.
• Employed VACV expressing costimulatory molecules (CD80/CD86) to assess their role in modulating immunodominance.

Main Results:

• Peripheral routes (i.d., s.c.) resulted in sharper immunodominance compared to systemic routes (i.p., i.v.).
• Priming in lymph nodes, while necessary, was not sufficient for broadening T cell responses; spleen priming was also critical.
• VACV expressing CD80/CD86 reduced immunodominance after i.d. but not i.p. infection, suggesting costimulation is a contributing factor.

Conclusions:

• Limited priming resources in local draining lymph nodes contribute to increased immunodominance via peripheral routes.
• Costimulation via molecules like CD80/CD86 can be a limiting factor in CD8(+) T cell priming and immunodominance.
• Understanding route-dependent immunodominance and epitope breadth is crucial for effective viral and vaccine immunology research.